ABL1 and amyotrophic lateral sclerosis: In contrast to the ACMs obtained from ALS astrocytes, chronic application of STI571 with control ACM-hSOD1WT did not alter c-Abl intensity in motoneurons (Figure 2C4) or number of surviving motoneurons (Figure 2E).